News
The latest milestones and updates from New Dimensions Health
Transactional News
Equity investment in ELMNT IR
NDH closed its first transaction, an equity investment in ELMNT IR, a multi-site outpatient interventional radiology company co-founded by NDH Managing Partner Steven Yecies, moving high-impact Interventional Radiology procedures out of hospitals into modern outpatient centers.
Focus
Concentrated bets on companies that already work
$50–250M — Typical check size
Early-stage and growth
We accelerate the growth of established healthcare services, IT, and AI enterprises by providing the capital and operational guidance necessary to dominate their respective markets.
50+ — Prior healthcare investments
Across our team's careers
Portfolio
A history of building and backing category leaders
Active
Realized
New, 2026
ELMNT IR*
Ambra Health* → Intelerad
Caris Life Sciences
IPO
US
Augmedix* → IPO
Cyrus Biotech
IPO
US
Axial Exchange* → Ingage
MDClone
Acquisition
Israel
Guardant Health → IPO
MobileODT
IPO
Israel
Health Catalyst → IPO
MY DR NOW*
IPO
US
Hitouch Health* → SoftBank Singapore
PERA Health*
Strategic Sale
US
Invitae → IPO
Sikka Software*
IPO
US
Javelin Oncology* → Genmab
Tyto Care
Acquisition
Israel
NetMeds → Reliance
Strategic Sale
Practice Fusion* → Veradigm
Strategic Sale
Proteus → Otsuka
Strategic Sale
Teladoc → IPO
IPO
TigerConnect* → Vista Equity
Strategic Sale
* NDH member serves or WAS Chair or member of the Board of Directors
About
Operators first. Investors second
Steven Yecies
Founder & Managing Partner
As Managing Partner, Steven directs investment strategy, leveraging a career defined by operational leadership and elite primary care and health-tech exits. He previously spearheaded healthcare IT and services at OrbiMed Advisors and Kain Capital. A prolific builder, he scaled over 40 global e-health ventures as the leader of Scient’s healthcare practice and has served as founder or CEO for seven startups. His track record includes partnering with founders to achieve significant value creation through high-profile IPOs and strategic acquisitions of category-leading companies across the US and international markets.
Anne Barr
Former CIO/CSIO at Brown & Toland, and senior IT leadership at Sutter Health and Kaiser Permanente. Deep expertise in business transformation, IT innovation and AI, and cybersecurity. MBA, Harvard; AB, Dartmouth.
Dr. Stephen Bloch
Co-founder & CEO of EvolveImmune; General Partner, Canaan Partners. Founded Radiology Management Sciences with Mr. Yecies and co-invested in Ambra Health. MD, University of Rochester; radiology training at MGH/Harvard.
Dr. Shubhra Jain
Head of healthcare investments at Tarsadia Investments; former Principal at Cota Capital. Supports NDH on diligence, fundraising, and portfolio operations. MD; MBA, Wharton; MS Mechanical Engineering, Stanford.
Dr. C. Anthony Jones
Co-founder & CEO of Frontive Health; former VP & CMO at Philips Healthcare. Worked with Mr. Yecies at Scient. MD, Johns Hopkins; Medical Informatics fellowship, Columbia.
Anat Naschitz
Co-Founder & Managing Partner, 9VC/9xchange; former Co-Founder & Managing Director, OrbiMed Israel, collaborating with Mr. Yecies on TytoCare, MDClone, MobileODT, and Treato. MBA, INSEAD; LLB, Tel Aviv University.